GEXVal Focuses On Rare Diseases As It Builds On Ex-Takeda Assets
Executive Summary
Emerging Company Profile: Japanese company GEXVal is one of several bioventures formed from the spin-out of researchers and assets from Takeda, and is focused on bringing therapies of value to patients with rare diseases, including a novel molecule for pulmonary arterial hypertension.